Cognitive Reserve Is a Determinant of Health-related Quality of Life in Patients With Cirrhosis, Independent of Covert Hepatic Encephalopathy and Model for End-Stage Liver Disease Score

被引:22
|
作者
Patel, Ankit V. [1 ]
Wade, James B. [2 ]
Thacker, Leroy R. [3 ,4 ]
Sterling, Richard K. [1 ]
Siddiqui, Muhammad S. [1 ]
Stravitz, R. Todd [1 ]
Sanyal, Arun J. [1 ]
Luketic, Velimir [1 ]
Puri, Puneet [1 ]
Fuchs, Michael [1 ]
Matherly, Scott [1 ]
White, Melanie B. [1 ]
Unser, Ariel [1 ]
Heuman, Douglas M. [1 ]
Bajaj, Jasmohan S. [1 ]
机构
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23249 USA
[2] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23249 USA
[3] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23249 USA
[4] McGuire VA Med Ctr, Richmond, VA USA
关键词
Minimal Hepatic Encephalopathy; Prognostic Factor; Coping; Daily Function; Intelligence Quotient; BRAIN RESERVE; MULTIPLE-SCLEROSIS; REPORTED OUTCOMES; DIAGNOSIS; IMPACT; MORTALITY; DEMENTIA; DECLINE; BURDEN;
D O I
10.1016/j.cgh.2014.09.049
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Covert hepatic encephalopathy (CHE) is associated with cognitive dysfunction, which affects daily function and health-related quality of life (HRQOL) in patients with cirrhosis. The effects of CHE and liver disease are determined by cognitive reserve-the ability of the brain to cope with increasing damage while continuing to function-and are assessed by composite intelligence quotient (IQ) scores. We examined cognitive reserve as a determinant of HRQOL in patients with cirrhosis. METHODS: We performed a prospective study of 118 outpatients with cirrhosis without overt HE (age, 56 y). We studied cognition using the standard paper-pencil battery; patients with below-normal results for more than 2 tests were considered to have CHE. We also assessed HRQOL (using the sickness impact profile [SIP]), psychosocial and physical scores (a high score indicates reduced HRQOL), model for end-stage liver disease (MELD) scores, and cognitive reserve (using the Barona Index, a validated IQ analysis, based on age, race, education, residence area, and occupation). Cognitive reserve was divided into average and high groups (<109 or >109), and MELD and SIP scores were compared. We performed regression analyses, using total SIP score and psychosocial and physical dimensions as outcomes, with cognitive reserve, CHE, and MELD score as predictors. RESULTS: Study participants had average MELD scores of 9, and 14 years of education; 81% were white, 63% were urban residents, their mean IQ was 108 +/- 8, and 54% had average cognitive reserve (the remaining 46% had high reserves). CHE was diagnosed in 49% of patients. Cognitive reserve was lower in patients with CHE (109) than without (105; P = .02). Cognitive reserve correlated with total SIP and psychosocial score (both r = -0.4; P < .001) and physical score (r = -0.3; P = .01), but not MELD score (P = .8). Patients with high cognitive reserve had a better HRQOL, despite similar MELD scores. In regression analyses, cognitive reserve was a significant predictor of total SIP (P < .001), psychosocial (P < .001), and physical scores (P < .03), independent of CHE, MELD, or psychiatric disorders. CONCLUSIONS: A higher cognitive reserve is associated with a better HRQOL in patients with cirrhosis, despite similar disease severity and prevalence. This indicates that patients with good cognitive reserve are better able to withstand the demands of cirrhosis progression and CHE, leading to a better HRQOL. Patients with lower cognitive reserve may need more dedicated and earlier measures to improve HRQOL. Cognitive reserve should be considered when interpreting HRQOL and cognitive tests to evaluate patients with cirrhosis.
引用
收藏
页码:987 / 991
页数:5
相关论文
共 50 条
  • [21] Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
    Prasad, Srinivasa
    Dhiman, Radha K.
    Duseja, Ajay
    Chawla, Yogesh K.
    Sharma, Arpita
    Agarwal, Ritesh
    HEPATOLOGY, 2007, 45 (03) : 549 - 559
  • [22] Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?
    Rodrigue, James R.
    Nelson, David R.
    Reed, Alan I.
    Hanto, Douglas W.
    Curry, Michael P.
    PROGRESS IN TRANSPLANTATION, 2011, 21 (03) : 207 - 214
  • [23] Quality of Life and Health-related Quality of Life in Patients with End-stage Kidney Disease Undergoing Hemodialysis: A Literature Review
    Al-Rajhi, Waleed
    Al Salmi, Issa
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2022, 33 : S184 - S230
  • [24] Does model for end-stage liver disease (meld) score correlate with quality of life?
    Byrne, TJ
    Douglas, DD
    Vargas, HE
    Balan, VC
    Harrison, ME
    Moss, A
    Reddy, KS
    Rakela, J
    Mulligan, DC
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 219 - 219
  • [26] Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis
    Sheng, Qin-Song
    Lang, Ren
    He, Qiang
    Yang, Yong-Jiu
    Zhao, De-Fang
    Chen, Da-Zhi
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2009, 8 (01) : 46 - 49
  • [27] Model for End-Stage Liver Disease and liver cirrhosis-related complications
    Luis Calzadilla Bertot
    Eduardo Vilar Gomez
    Linnet Alonso Almeida
    Enrique Arus Soler
    Luis Blanco Perez
    Hepatology International, 2013, 7 : 347 - 355
  • [28] Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease
    Niilo Färkkilä
    Saku Torvinen
    Risto P. Roine
    Harri Sintonen
    Juha Hänninen
    Kimmo Taari
    Tiina Saarto
    Quality of Life Research, 2014, 23 : 1387 - 1394
  • [29] Model for End-Stage Liver Disease and liver cirrhosis-related complications
    Calzadilla Bertot, Luis
    Vilar Gomez, Eduardo
    Alonso Almeida, Linnet
    Arus Soler, Enrique
    Blanco Perez, Luis
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 347 - 355
  • [30] Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
    Ming Pei
    Rute Aguiar
    Agneta A. Pagels
    Olof Heimbürger
    Peter Stenvinkel
    Peter Bárány
    Charlotte Medin
    Stefan H. Jacobson
    Britta Hylander
    Bengt Lindholm
    Abdul Rashid Qureshi
    BMC Nephrology, 20